Lasa Supergenerics narrows net loss to ₹416.44 lakh in Q4FY26
Lasa Supergenerics narrowed its net loss to ₹416.44 lakh for Q4FY26 from ₹1,429.11 lakh in Q4FY25, with revenue from operations falling to (₹13.15) lakh due to a production halt caused by a fire incident. The statutory auditor, Gupta Rustagi & Co., issued a qualified opinion due to insufficient evidence on the fire's financial impact and the lack of impairment assessment for intangible assets worth ₹1,667.05 lakh. For the full year FY26, the company reported a net loss of ₹3,409.03 lakh on a total income of ₹2,534.05 lakh, while facing operational challenges like labour unrest.

*this image is generated using AI for illustrative purposes only.
Lasa Supergenerics reported a net loss of ₹416.44 lakh for the quarter ended March 31, 2026, a significant improvement from the net loss of ₹1,429.11 lakh in the corresponding quarter of the previous year. Revenue from operations for the quarter stood at (₹13.15) lakh, a steep decline from ₹3,913.77 lakh in Q4FY25, primarily due to a complete halt in production following a fire incident at its Ratnagiri factory. The company’s total income for the quarter was (₹9.08) lakh.
The Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026. The statutory auditor, Gupta Rustagi & Co., issued a qualified opinion on the financial results. The qualification cites insufficient appropriate audit evidence regarding the completeness and accuracy of the financial impact of the fire incident that occurred on May 18, 2025. Additionally, the auditor qualified the opinion regarding the impairment of intangible assets, which include patents, goodwill, and software aggregating to ₹1,667.05 lakh, as the company has not carried out an impairment assessment.
Financial Performance
| Particulars | Quarter ended Mar 31, 2026 (₹ in Lakhs) | Quarter ended Mar 31, 2025 (₹ in Lakhs) |
|---|---|---|
| Revenue from Operations | (13.15) | 3,913.77 |
| Total Income | (9.08) | 4,152.94 |
| Total Expenses | 342.32 | 3,973.16 |
| Net Profit / (Loss) | (416.44) | (1,429.11) |
| Earnings Per Share (Basic) | (0.83) | (2.85) |
For the full year ended March 31, 2026, the company reported a net loss of ₹3,409.03 lakh on a total income of ₹2,534.05 lakh. The auditor emphasized the write-off of Capital Work-in-Progress amounting to ₹46.27 lakh during the year as an exceptional item. The company faces significant operational challenges, including labour unrest and obstruction by an unrecognized union preventing access to the factory for damage assessment. The management stated it is exploring alternative options such as contract manufacturing or leasing the facility to restore operations.
Historical Stock Returns for Lasa Supergenerics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.84% | +1.71% | +2.72% | -12.80% | -47.96% | -89.34% |
What is the estimated timeline for resuming production at the Ratnagiri factory given the ongoing labor unrest?
How will the company fund operations and fixed costs during the extended halt in production?
What specific steps will management take to address the auditor's concerns regarding the impairment assessment of intangible assets?


































